Covered recipient · General Payments record
JANINE SANTORA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$16,956.89
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $529.41 | 18 |
| Consulting Fee | $520.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $625.76 | 2 |
| ABBVIE INC. | $301.80 | 16 |
| Lilly USA, LLC | $121.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.83 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144315 | CMS |
| ABBVIE INC. | $9.39 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144317 | CMS |
| ABBVIE INC. | $8.48 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144319 | CMS |
| ABBVIE INC. | $113.19 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144321 | CMS |
| ABBVIE INC. | $8.02 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144323 | CMS |
| ABBVIE INC. | $10.74 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144325 | CMS |
| ABBVIE INC. | $12.73 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144327 | CMS |
| ABBVIE INC. | $15.63 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144329 | CMS |
| ABBVIE INC. | $9.54 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144331 | CMS |
| ABBVIE INC. | $13.69 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144333 | CMS |
| ABBVIE INC. | $56.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144335 | CMS |
| ABBVIE INC. | $7.54 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144337 | CMS |
| ABBVIE INC. | $10.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144339 | CMS |
| ABBVIE INC. | $5.85 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144341 | CMS |
| ABBVIE INC. | $5.63 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144343 | CMS |
| ABBVIE INC. | $8.35 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108144345 | CMS |
| Eisai Inc. | $520.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110804258 | CMS |
| Eisai Inc. | $105.76 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110804256 | CMS |
| Lilly USA, LLC | $121.85 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135691258 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.